Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary interventionRichard G. Jung, Benjamin Hibbert, Robert B. Moreland et al.|Thrombosis Research|2020Cited by 10
Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisationRichard G. Jung, Benjamin Hibbert, Omar Abdel‐Razek et al.|Open Heart|2022Cited by 1
TCT-103 Impact of Preexisting and New Atrial Fibrillation on Major Adverse Cardiac Events After Coronary RevascularizationOmar Abdel‐Razek, Benjamin Hibbert, Richard Jung et al.|Journal of the American College of Cardiology|2022Cited by 0